Securities Repurchase and CVR Agreement Sample Contracts

INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF...

Securities Repurchase and CVR Agreement • May 26th, 2023 • Takeda Pharmaceutical Co LTD • Pharmaceutical preparations • Delaware

• Contract Type
  Securities Repurchase and CVR Agreement
• Filed
  May 26th, 2023
• Company
  Takeda Pharmaceutical Co LTD
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Securities Repurchase and CVR Agreement (this “Agreement”) is dated as of April 17, 2023, between Calithera Biosciences, Inc., a Delaware corporation (the “Company”) and Takeda Ventures, Inc. (the “Stockholder”).